Managing bite wounds: Currently recommended antibiotics for treatment and prophylaxis

Postgraduate Medicine

Volumn 116, Issue 2, 2004, Pages 49-59

  Taplitz, Randy A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BAYRAB; CARBAPENEM DERIVATIVE; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DIPLOID CELL VACCINE; DOXYCYCLINE; ERYTHROMYCIN; IMOGAM RABIES HT; KETOLIDE; MACROLIDE; NAFCILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RABIES IMMUNOGLOBULIN; RABIES VACCINE; SULTAMICILLIN; TETANUS TOXOID; TIMENTIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BITE WOUND; DEBRIDEMENT; DOG BITE; HUMAN; INFECTION CONTROL; INFECTION RISK; PHYSICAL EXAMINATION; RABIES; REVIEW; TETANUS; WOUND CARE; WOUND CLOSURE; WOUND INFECTION; WOUND IRRIGATION;

EID: 4043182806     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2004.08.1572     Document Type: Review

References (24)

1. Weiss H, Friedman D, Coben J. Incidence of dog bite injuries treated in emergency departments. JAMA 1998;279(1):51-3
2. Goldstein E. Bite wounds and infection. CID 1992;14:633-40
3. Smith P, Meadowcroft A, May D. Treating mammalian bite wounds. J Clin Pharm Ther 2000;25:85-99
4. Abrahamian F. Dog bites: bacteriology, management, and prevention. Curr Infect Dis Rep 2000;2(5):446-53
5. Talan D, Citron D, Abrahamian F, et al. Bacteriologic analysis of infected dog and cat bites. N Engl J Med 1999;340(2):85
6. Perron A, Miller M, Brady W. Orthopedic pitfalls in the ED: fight bite. Am J Emerg Med 2002;20(2):114-7
7. Kelly I, Cunney R, Smyth E, et al. The management of human bite injuries in the hand. Injury: Int J Care Injured 1996;27(7):481-4
8. Morrison G. Zoonotic infections from pets. Postgrad Med 2001;110(1):24-48
9. Montejo M, Aguirrebengoa K, Ugalde J, et al. Bergeyella zoohetcum bacteremia after a dog bite. Clin Infect Dis 2001;33:1608-9
10. Pers C, Gahrn-Hansen B, Frederiksen W. Capnocytophaga canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clin Infect Dis 1996;23(1):71-5
11. Kaiser R, Garman R, Bruce M, et al. Clinical significance and epidemiology of NO-1, an unusual bacterium associated with dog and cat bites. Emerg Infect Dis 2002;8(2):171-4
12. Fajfar-Whetstone C, Coleman L, Biggs D, et al. Pasteurella multocida septicemia and subsequent Pasteurella dagmatis septicemia in a diabetic patient. J Clin Microbiol 1995;33(1):202-4
13. Paul K, Patel S. Eikenella corrodens infections in children and adolescents: case reports and review of the literature. Clin Infect Dis 2001;(33):54-61
14. Fleisher G. The management of bite wounds. N Engl J Med 1999;340(2):138-40
15. Chen E, Horning S, Shepherd S, et al. Primary closure of mammalian bites. Acad Emerg Med 2000;7(2):157-61
16. Callaham M. Prophylactic antibiotics in dog bite wounds: nipping at the heels of progress. Ann Emerg Med 1994;23(3):577-9
17. Cummings P. Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials. Ann Emerg Med 1994;23(3):535-40
18. Jones N. Infected dog and cat bites. N Engl J Med 1999;340(23):1841-2
19. Goldstein E, Citron D, Merriam C, et al. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections. Antimicrob Agents Chemother 2000;44(9):2525-9
20. Goldstein E, Citron D, Merriam C, et al. Comparative in vitro activity of ertapenam and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections. J Antimicrob Chemother 2001;48:641-51
21. Goldstein E, Citron D, Merriam C, et al. In vitro activities of the des-fluoro(6) quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections. Antimicrob Agents Chemother 2002;46(3):886-70
22. Goldstein E, Citron D, Gerardo S, et al. Activities of HMR 3004 (RU64004) and HMR 3647 (RU66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. Antimicrob Agents Chemother 1998;45(5):1127-32
23. Centers for Disease Control and Prevention. Human rabies prevention-United States 1999. MMWR Morb Mortal Wkly Rep 1999;48 (RR-1):1-21
24. Centers for Disease Control and Prevention. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 2003:1-28